Zydus Cadila

Centre will decide on vaccination of children, adolescents on ‘scientific rationale’, says COVID Task Force chief

Zydus Cadila’s needle-free vaccine ZyCoV-D is set to become the first vaccine that will be available in India for those in the age group of 12-18 years

Covaxin recommended by expert panel for kids: All you need to know about children's COVID-19 shot

Children will be given half the proportion of what adults get ie, a dose of 0.5 ml will be given to kids compared to 1ml in adults. It will be an intramuscular injection like other vaccines

Conversation between Zydus Cadila, Centre underway on pricing for first DNA-based needle-free COVID-19 vaccine

The pharma company is learnt to have proposed ₹1,900 for its three-dose jab that can be given to those above 12 years of age.

Zydus Cadila proposes Rs 1,900 for three-dose COVID vaccine; Centre negotiating to bring price down

The government had said that the indigenously-developed, world's first DNA-based needle-free COVID-19 vaccine by Zydus Cadila will be introduced in the nationwide anti-coronavirus vaccination drive shortly.

From Merck’s Molnupiravir to Glenmark’s nasal spray, over 20 new drugs in pipeline for COVID-19

While the market for these drugs may not be huge at present due to a drop in COVID-19 cases and extended timelines, experts believe that these drugs will help control future waves and protect people with weak immunity

Centre working with Zydus Cadila on pricing of ZyCoV-D vaccine; likely to launch on 2 October

The government is aiming to roll out India’s first approved vaccine for kids aged 12 years and above on 2 October, the birthday of Mahatma Gandhi

Over 70.63 crore COVID-19 vaccine doses provided to states and UTs thus far, says Centre

The health ministry said more than 5.58 crore balance and unutilised COVID-19 vaccine doses are still available with the states and UTs to be administered

ZyCoV-D to come at "affordable price", market launch likely by Sept end, says Zydus group MD

ZyCoV-D was approved by the country’s apex drug regulator, Drug Controller General of India (DCGI), on August 20. The first indigenously-developed vaccine in India is Bharat Biotech’s Covaxin.

Zydus Cadila's COVID-19 vaccine okayed in India: From interval between doses to efficacy, here's what you must know

The Zydus Cadila vaccine, world's first to use the DNA technology against Sars-Cov-2, is 66 percent effective and expected to hit the market late September or early October

Zydus Cadila vaccine gets EUA for adolescents: A look at scientific, ethical concerns in inoculating minors for COVID-19

Nations like the US, the UK, France, have already begun vaccinating their adolescent population, while Israel, Chile and Malta have achieved one of the highest COVID-19 vaccination rates in the world